<DOC>
	<DOC>NCT01133431</DOC>
	<brief_summary>To assess the pharmacokinetic Interaction between CKD-501 and sulfonylurea (Glimepiride) in healthy male subjects.</brief_summary>
	<brief_title>The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea</brief_title>
	<detailed_description />
	<mesh_term>Glimepiride</mesh_term>
	<criteria>Healthy male adults aged between 20 and 45 during screening period Weight more than 45kg and within Â±20% range of Ideal Boby Weight Agreement with written informed consent Subject has signs of symptoms of acute disease within 28 days of starting administration of investigational drug Subject has a history(such as inflammatory gastrointestinal disease, gastric or duodenal ulcer, liver diseases, gastrointestinal surgical histories except for an appendectomy) affects the ADME of drug Clinically significant, active gastrointestinal system, cardiovascular system, pulmonary system, renal system, endocrine system, blood system, digestive system, central nervous system, mental disease or malignancy Inadequate subject by medical examination(medical history, physical examination, ECG, laboratory test) within 28 days of starting administration of investigational drug Inadequate laboratory test result AST(SGOT) or ALT(SGPT) &gt; 1.25 x upper limit of normal range Total bilirubin &gt; 1.5 x upper limit of normal range Clinically significant allergic disease(except for mild allergic rhinitis is not needed medication) Subject with known for hypersensitivity reactions to glitazones or sulfonylureas Previously participated in other trial within 60 days Medication with drugmediated induction/inhibition metabolic enzyme such as barbiturates within 1 month or with may affect the clinical trial within 10 days Subject has taken abnormal meals which affects the ADME of drug Impossible to taking the institutional standard meal Previously donate whole blood within 60 days or component blood within 20 days Continued to be taking caffeine (caffeine &gt; 5 cup/day), drinking(alcohol &gt; 30 g/day) or cannot stop drinking or severe heavy smoker(cigarette &gt; 10 cigarettes per day)during clinical trials An impossible one who participates in clinical trial by investigator's decision including laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>CKD-501</keyword>
	<keyword>Glimepiride</keyword>
	<keyword>Placebo</keyword>
	<keyword>Healthy male volunteer</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Metabolite</keyword>
</DOC>